new indications for glp-1 drugs Long-term Success of GLP-1s Hinges on More Than Just a Prescription GLP-1 Drug Overdose

Description

It received FDA approval on August 22, 2008

However, Park says the type of GLP-1 and how much of it you take may have an effect

The decision comes after the European Medicines Agency and the U.K.'s Medicines and Healthcare products Regulatory Agency (MHRA) said recently they were also reviewing the drugs because of reports that people's mental health had been impacted

However, potential adverse mental health effects have also been reported and require vigilance: Nausea and gastrointestinal symptoms , common side effects of GLP-1 medications, may increase anxiety in susceptible individuals Rapid weight loss can occasionally trigger psychological distress or exacerbate eating disorder behaviours Mood changes , including low mood, have been reported in post-marketing surveillance, though causality remains uncertain Some patients report feeling emotionally flat or detached , though this is anecdotal and not well characterised in clinical trials The Summary of Product Characteristics (SmPC) for GLP-1 receptor agonists used for weight management (such as Saxenda and Wegovy) includes specific warnings about monitoring for mood disorders and suicidal thoughts